• Study on the Effects of Botulinum Toxin in Patients with Jaw Muscle Pain (TMD)

    Recruiting

    2 1 1 1
    Sweden

  • Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Germany Hungary Italy Poland +1

  • Study on the Long-Term Safety of Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland Spain

  • Study Comparing Sirolimus and Methylprednisolone for Patients with Active Thyroid Eye Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway

  • Long-Term Safety Study of GLM101 for Patients with PMM2-CDG

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Italy Portugal Spain

  • Study on Dinutuximab Beta with Chemotherapy for Children and Teens with Newly Diagnosed High-Risk Neuroblastoma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Austria France Germany Italy The Netherlands Poland +1

  • Study on the Effects of Finerenone in Patients with Heart Failure and Preserved Ejection Fraction Hospitalized for Acute Decompensated Heart Failure

    Recruiting

    3 1
    Investigated Drugs:
    Austria Bulgaria Croatia Czechia Germany Greece +9

  • Study on Datopotamab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic Endometrial, Gastric, Prostate, Ovarian, Colorectal, Urothelial, and Biliary Tract Cancers

    Recruiting

    2 1 1 1
    Investigated Drugs:
    France Italy Poland Spain

  • Study of MDNA11 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1 1
    Investigated Drugs:
    Ireland Poland Portugal Spain

  • Study of Lenvatinib, Pembrolizumab, and Chemotherapy Combination for Patients with Advanced Esophageal Cancer Previously Treated with PD-1/PD-L1 Therapy

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Germany Italy Norway

powered by